Apotex a ‘standout’ stock since IPO despite Trump tariff threat, analysts say
· sophia bertuzzi
Source Summary
Drug maker rebounded last week, trading 30 per cent higher than at its debut
Advertisement
← CA Feed BUSINESS
Summarized daily news